Latest filing published 21 Oct 2025 for Vor Biopharma Inc., €638k. Read the official filing
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Reprogrammed Interchange LLC discloses dealings in Vor Biopharma Inc. to SEC (Form 4). The record holds 13 filings, for trades running from 30 December 2024 to 17 October 2025.
Both buying and selling appear: 1 purchase, against 12 sales worth €9.0M. The amount is not disclosed for 1 filing. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. So far in 2025, the count stands at 1 purchase and 12 sales.
Most recently, on 21 October 2025, the filings show an open-market sale worth €638k in Vor Biopharma Inc. The last insider purchase was made public on 2 January 2025, 654 days ago. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. The legal deadline for a Form 4 is two business days after the transaction. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
13 of 13 declarations